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ABSTRACT
The potential of expression analysis using cDNA
microarrays to address complex problems in a wide
variety of biological contexts is now being realised.
A limiting factor in such analyses is often the
amount of RNA required, usually tens of micro-
grams. To address this problem researchers have
turned to methods of improving detection sensitiv-
ity, either through increasing ¯uorescent signal
output per mRNA molecule or increasing the
amount of target available for labelling by use of an
ampli®cation procedure. We present a novel DNA-
based method in which an oligonucleotide is
incorporated into the 3¢ end of cDNA during second-
strand cDNA synthesis. This sequence provides an
annealing site for a single complementary heel
primer that directs Taq DNA polymerase ampli®ca-
tion of cDNA following multiple cycles of denatura-
tion, annealing and extension. The utility of this
technique for transcriptome-wide screening of rela-
tive expression levels was compared to two alterna-
tive methodologies for production of labelled cDNA
target, namely incorporation of ¯uorescent nucleo-
tides by reverse transcriptase or the Klenow frag-
ment. Labelled targets from two distinct mouse
tissues, adult liver and kidney, were compared by
hybridisation to a set of cDNA microarrays contain-
ing 6500 mouse cDNA probes. Here we demonstrate,
through a dilution series of cDNA derived from 10 mg
of total RNA, that it is possible to produce datasets
comparable to those produced with unampli®ed
targets with the equivalent of 30 ng of total RNA.
The utility of this technique for microarray analysis
in cases where sample is limited is discussed.
INTRODUCTION
Expression analysis using DNA microarrays is rapidly
becoming the method of choice for researchers wishing to
identify differentially expressed transcripts in tissues of
interest (for reviews see 1±3). However, for many researchers,
such as developmental biologists, the requirement for large
amounts of starting RNA, usually 10±100 mg of total RNA,
frequently prohibits the analysis of speci®c structures or cells
of interest. Several different approaches have been taken to
address this issue. These fall primarily into two groups: either
attempting to increase the ¯uorescent signal output per
molecule, such as the use of the dendrimer technology (4),
tyramide signal ampli®cation (5) and amino-allyl labelling
(6); or increasing the amount of target available for labelling
through ampli®cation, such as TPEA (7), RAGE (8), SMART-
PCR (9) and in vitro transcription (IVT) (10±13).
Concerns arising from use of these technologies include
reproducibility, reliability, conservation of differential expres-
sion, associated costs and ease of use. Here we describe a
novel single primer ampli®cation (SPA) method for use with
spotted microarrays that addresses each of these concerns. The
®rst steps in this protocol generate double-stranded cDNA,
initially primed by a modi®ed oligo(dT) primer. A primer
equivalent to the heel of the modi®ed oligo(dT) primer is then
used to direct semi-linear Taq DNA polymerase ampli®cation.
The protocol is essentially a modi®ed cycle sequencing
reaction, familiar and accessible to the majority of molecular
biologists.
MATERIALS AND METHODS
RNA extraction
Total RNA was extracted from adult female mouse liver and
kidney (strain 3H1) using Trizol (Invitrogen) followed by a
RNeasy midi kit (Qiagen) according to the manufacturer's
instructions. The quantity and quality of RNA was assessed
using a Bioanalyzer 2100 (Agilent). RNA samples were
pooled and aliquoted to ensure technical comparisons would
not represent differences in RNA source or quality.
Target preparation
Preparation of labelled target cDNA for hybridisation to
microarray slides was carried out using one of three methods.
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Reverse transcriptase (RT) labelling. For the standard RT
labelling method 100 mg of total RNA was heated for 10 min
at 70°C in the presence of 4 mg oligo(dT15) (total volume
24 ml). Samples were cooled to 42°C and 26 ml labelling
reaction mixture added [10 ml 53 RT buffer (BRL); 5 ml 0.1 M
DTT (BRL); 25 mM dATP, dGTP and dTTP, 2.5 mM dCTP
(Abgene); 1 mM Cy3 or Cy5-dCTP (APB); 2 ml RNase
inhibitor; 400 U M-MLV II (Superscript II; BRL)]. Samples
were incubated at 42°C for 4 h, with 200 U M-MLV II added
each hour. Following ®rst-strand cDNA synthesis, 20 mg
RNase A was added to each sample and incubated at 37°C for
20 min. Reactions were stopped by the addition of 5 ml 0.5 M
EDTA.
Klenow labelling. For labelling of unampli®ed RNA using
Klenow fragment, 20 mg total RNA was employed in ®rst- and
second-strand synthesis reactions, employing the `cDNA
synthesis system' (Roche, catalogue no. 1117831). First-
strand synthesis used oligo(dT) priming. Double-stranded
cDNA samples were puri®ed using a PCR puri®cation kit
(Qiagen) and eluted with 26 ml water. An aliquot of 5 ml was
subjected to gel electrophoresis to con®rm quantity and
quality. Samples were ¯uorescently labelled using the
genomic DNA protocol published online at http://cmgm.
stanford.edu/pbrown/protocols/4_genomic.html. Brie¯y, a
21 ml sample was mixed with 20 ml random octamer
oligonucleotides (Bioprime Kit; Invitrogen). Samples were
heated to 90°C for 5 min and snap cooled on ice. An aliquot of
5 ml 103 dNTP mix was added to each sample (1.2 mM each
dATP, dGTP and dTTP, and 0.6 mM dCTP), followed by
3 ml Cy5-dCTP or Cy3-dCTP (1 mM stocks; Amersham).
An aliquot of 1 ml high concentration Klenow fragment
(40±50 U/ml) was added and the samples incubated at 37°C for
2 h. Reactions were stopped by the addition of 5 ml 0.5 M
EDTA pH 8.0.
Single primer ampli®cation reactions. For production of SPA
cDNA, 10 mg of total RNA was used in ®rst- and second-
strand synthesis reactions, again employing the `cDNA syn-
thesis system' (Roche, catalogue no. 1117831). However, a
modi®ed oligonucleotide replacing oligo(dT) (5¢-AAACGA-
CGGCCAGTGAATTGTAATACGACTCACTATAGGCGC-
TTTTTTTTTTTTTTTTV-3¢) was used to prime ®rst-strand
synthesis. This oligonucleotide contains the T7 RNA poly-
merase promoter sequence. This was chosen as it represents a
non-eukaryotic sequence. We also utilised the heel primer
from the TPEA technique (7), with comparable results (data
not shown).
After completion of second-strand synthesis, samples were
puri®ed using a PCR puri®cation kit (Qiagen) and eluted
with 100 ml water. This 100 ml sample was taken to
represent 10 mg of starting RNA and dilutions representing
0.5±0.031 mg starting RNA were employed in the ampli®ca-
tion step. The assumption of 100% recovery after cDNA
synthesis and puri®cation is likely to overestimate the amount
of RNA represented in each sample. Ampli®cation reactions
were set up as follows. Aliquots of 10 ml 103 PCR buffer
(including a ®nal Mg2+ concentration of 1.5 mM), 10 ml
dNTPs at 2 mM concentration, 100 pmol HPLC puri®ed heel
primer (5¢-CGGCCAGTGAATTGTAATACGACTCACTA-
TAGGCG-3¢), 12.5 U Taq DNA polymerase (Abgene) and
cDNA template were combined in water to 100 ml total
volume. Reactions were placed in a tetrad thermocycler (MJ
Research) and incubated at 94°C for 3 min, then subjected to
40 cycles of 94°C (1 min), 59°C (1 min) and 72°C (2 min).
Samples were again puri®ed (Qiaquick PCR puri®cation kit;
Qiagen) and labelled using the method described in the
Klenow labelling section above.
Microarray construction
Microarrays were manufactured using CMT-GAPS II slides
(Corning) with a MicroTAS arrayer (BioRobotics). PCR probe
elements were manufactured from plates 17±32 of the NIA
mouse developmental set (14). PCR ampli®cations were
performed incorporating 5 ml 103 PCR buffer, 5 ml 2 mM
dNTPs, 2.5 ml 10 mM each primer (5¢-CCAGTCACGACGT-
TGTAAAACGAC-3¢ and 5¢-NH2-GTGTGGAATTGTGAG-
CGGATAACAA-3¢), 0.125 ml HotStart Taq DNA polymerase
(Qiagen), 37.5 ml 1:10 glycerol stock and water to 150 ml. PCR
samples were incubated at 95°C for 10 min, then subjected to
30 cycles of 95°C for 1 min, 60°C for 2 min and 72°C for
7 min. A ®nal incubation step of 72°C for 10 min was carried
out.
Ampli®cation reactions were then puri®ed using
Multiscreen-PCR plates (Millipore) and eluted into 100 ml
water. Two microlitres was subjected to agarose gel electro-
phoresis to determine quality and yield. Remaining sample
was precipitated and resuspended in 25 ml arraying solution
(150 mM sodium phosphate buffer pH 8.5, 0.001% sarkosyl).
Samples were submitted for arraying if a single band was
observed upon gel electrophoresis and a concentration
between 250 and 500 ng/ml was obtained. Each EST probe
was spotted on each slide in duplicate.
Microarray hybridisation
Following termination of the labelling reactions individual
samples were mixed with the correctly labelled corresponding
sample and passed through a nucleotide removal kit (Qiagen).
Mouse Cot-1 DNA (10 mg) and 20 mg of T7-dT primer/
oligo(dA)/oligo(dT) (ampli®ed target/RT labelled target/
Klenow labelled target, respectively) were then added to the
mixed sample. Sample volume was reduced to 10 ml using a
speed vac (Heto) and mixed with 30 ml hybridisation solution
to give a ®nal concentration of 50% formamide, 63 SSC,
0.2% SDS. Samples were heated to 80°C for 5 min then placed
at 42°C for 30 min to allow repeat blocking. Samples were
brie¯y subjected to centrifugation and pipetted beneath
coverslips onto microarray slides incubated on a hot block at
42°C. Microarrays were placed into hybridisation chambers
(Corning), the end wells were ®lled with 10 ml hybridisation
buffer and the chambers sealed. Microarrays were placed in a
waterbath at 42°C overnight.
Microarray washing
Microarrays were removed from the hybridisation chambers
and washed in 23 SSC for 3 min; 0.13 SSC, 0.1% SDS for
3 min; 0.13 SSC for 3 min. Slides were dried by
centrifugation for 5 min at 60 g and entered for scanning.
Data capture and analysis
Microarrays were scanned using an Affymetrix 428 scanner,
producing a 16 bit tif ®le for each of the dyes used. The
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images were analysed and data quanti®ed using ImaGene 4.1
(BioDiscovery). During image processing, an automatic
¯agging process was used to remove spots whose back-
ground-subtracted mean signal intensity was less than four
times the standard deviation of the background pixel intensity.
The cut-off level of four was chosen due to previous
observations made with the hardware/software combination.
This level was found to be most ef®cient at removing
background level spots without ¯agging genuine signal.
Manual ¯agging was also used to highlight spot irregularities
such as dust, scratches and misaligned features. Data for each
experiment were scaled for intensity using a least squares
regression technique where each individual kidney data set
was scaled against the mean of all kidney data sets and
likewise for the liver data sets (Table 1) (15). Data were then
normalised using the robust scatter plot smoothing technique,
lowess, with print tip scaling from the `Statistical Microarray
Analysis' (16) library for statistical software package R (17).
On-slide duplicates were averaged and ®ltered to remove
¯agged data using GeneSpring (Silicon Genetics). Spots
¯agged in one or more arrays were excluded from further
analysis. Data were exported to R where differential genes
were selected from each slide using the single slide method
described by Newton et al. (18). These lists of genes identi®ed
as signi®cantly different on each slide were combined for the
four slides within each target preparation methodology.
The reproducibility of the techniques was analysed by
performing analysis of variance (ANOVA) on ®ltered datasets
using SPSS.
RESULTS
Technique overview
SPA, as for IVT ampli®cation, relies upon the use of a
modi®ed oligo(dT) primer to drive ®rst-strand cDNA synthe-
sis. The complement to this primer is incorporated into every
transcript following second-strand synthesis. A primer com-
plementary to the speci®c oligo in the oligo(dT) sequence then
binds to the denatured second-strand cDNA and drives
ampli®cation by Taq DNA polymerase cycling extensions
(similar to cycle sequencing).
Experimental design
We performed 30 dual hybridisation microarray experiments
using adult mouse kidney and liver RNA in order to determine
the effect of single primer ampli®cation on expression ratios
obtained when compared to conventional labelling techniques
Table 1. Experimental design
Microarray Labelling
method
Relative amount Kidney label Liver label cDNA
synthesis
Regression line between each
kidney channel and mean of all
kidney channels
Regression line between each
liver channel and mean of all
liver channels
1 RT 100 Cy 5 Cy 3 5 y = 0.80x + 0.35 y = 1.09x ± 0.76
2 RT 100 Cy 3 Cy 5 6 y = 0.73x + 0.60 y = 1.01x ± 0.34
3 RT 100 Cy 5 Cy 3 7 y = 0.95x ± 0.46 y = 0.79x + 0.44
4 RT 100 Cy 3 Cy 5 8 y = 0.97x ± 0.37 y = 0.82x + 0.50
5 Klenow 20 Cy 5 Cy 3 3 y = 1.01x ± 0.12 y = 0.66x + 1.05
6 Klenow 20 Cy 3 Cy 5 3 y = 0.76x + 0.70 y = 0.67x + 0.89
7 Klenow 20 Cy 5 Cy 3 4 y = 0.89x + 0.28 y = 0.74x + 0.80
8 Klenow 20 Cy 3 Cy 5 4 y = 0.74x + 0.52 y = 0.72x + 0.71
9 SPA 0.5 Cy 5 Cy 3 1 y = 0.92x ± 0.18 y = 1.18x ± 0.84
10 SPA 0.5 Cy 3 Cy 5 1 y = 1.15x ± 0.84 y = 1.05x ± 0.28
11 SPA 0.5 Cy 5 Cy 3 2 y = 1.07x ± 0.20 y = 1.32x ± 1.01
12 SPA 0.5 Cy 3 Cy 5 2 y = 1.18x ± 0.61 y = 1.04x ± 0.16
13 SPA 0.25 Cy 5 Cy 3 1 y = 1.10x ± 0.37 y = 1.29x ± 1.06
14 SPA 0.25 Cy 3 Cy 5 1 y = 1.13x ± 0.43 y = 1.03x ± 0.14
15 SPA 0.25 Cy 5 Cy 3 2 y = 1.14x ± 0.55 y = 1.39x ± 1.30
16 SPA 0.25 Cy 3 Cy 5 2 y = 1.37x ± 1.14 y = 1.16x ± 0.59
17 SPA 0.125 Cy 5 Cy 3 1 y = 0.94x + 0.33 y = 1.05x ± 0.03
18 SPA 0.125 Cy 3 Cy 5 1 y = 1.09x ± 0.38 y = 1.00x ± 0.17
19 SPA 0.125 Cy 5 Cy 3 2 y = 1.03x ± 0.17 y = 1.21x ± 0.69
20 SPA 0.125 Cy 3 Cy 5 2 y = 1.19x ± 0.62 y = 1.06x ± 0.19
21 SPA 0.0625 Cy 5 Cy 3 1 y = 0.92x + 0.08 y = 1.09x ± 0.43
22 SPA 0.0625 Cy 3 Cy 5 1 y = 1.11x ± 0.62 y = 1.02x ± 0.15
23 SPA 0.0625 Cy 5 Cy 3 2 y = 1.06x ± 0.23 y = 1.23x ± 0.73
24 SPA 0.0625 Cy 3 Cy 5 2 y = 1.12x ± 0.42 y = 1.01x ± 0.07
25 SPA 0.03125 Cy 5 Cy 3 1 y = 0.97x + 0.26 y = 1.07x ± 0.19
26 SPA 0.03125 Cy 3 Cy 5 1 y = 0.96x + 0.12 y = 0.89x + 0.25
27 SPA 0.03125 Cy 5 Cy 3 2 y = 1.00x ± 0.04 y = 1.16x ± 0.52
28 SPA 0.03125 Cy 3 Cy 5 2 y = 1.15x ± 0.51 y = 1.04x ± 0.18
29 SPA 0.5 Cy 5 & Cy 3 3 & 4 y = 1.12x ± 0.32, y = 0.96x + 0.27
30 SPA 0.5 Cy 5 & Cy 3 4 & 3 y = 1.25x ± 0.90, y = 1.02x ± 0.01
Dye incorporation methodology, dye orientation, relative amount of starting material and cDNA synthesis reaction number are shown for all 30 microarrays
(29 and 30 are self±self hybridisations). Also shown are two equations for the linear regression lines used to scale each data set against the mean of all data
sets for the kidney and liver channels, respectively.
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(Table 1). A single source of liver and kidney total RNA was
used for all experiments and either Cy3 or Cy5-dCTP was
incorporated during labelling. We labelled four kidney and
four liver RNA aliquots (100 mg) using direct incorporation by
reverse transcriptase (henceforth called RT labelling; see
Materials and Methods) and performed dual hybridisations in
duplicate with both orientations of dye incorporation (dye
swaps). Four equivalent hybridisations were performed using
two kidney and two liver RNA samples (20 mg) and random
primed labelling of ®rst-strand cDNA with Klenow fragment
(henceforth called Klenow labelling; see Materials and
Methods), again incorporating dye-swap controls. Finally,
two liver and two kidney samples were reverse transcribed
with a modi®ed oligo(dT) primer and converted to double-
stranded cDNA. Each cDNA synthesis was diluted to provide
®ve distinct starting concentrations equivalent to 0.5, 0.25,
0.125, 0.063 and 0.031 mg of total RNA. Each of these,
totalling 20, was then ampli®ed using the SPA method (see
Materials and Methods). Ampli®ed cDNA was labelled twice,
once with Cy3 and once with Cy5 incorporation, by Klenow
fragment using random priming (see Materials and Methods).
Twenty dual hybridisations were then performed with recip-
rocal labelling reactions from distinct ampli®cations (Table 1).
Figure 1 shows a schematic overview and representative
microarray images for the three techniques.
Data analysis: reliability and utility
One of the primary concerns of researchers conducting
ampli®cation for microarray analysis is the reproducibility
associated with the ampli®cation step itself. To address this
question self±self hybridisations derived from two independ-
ent SPA ampli®cations of both kidney and liver cDNA were
characterised. The Pearson correlation coef®cients for these
are r = 0.985 and r = 0.986 for kidney and liver, respectively.
To determine whether target cDNA ampli®cation had
affected our ability to reliably pro®le gene transcription in
the kidney and liver RNA samples, based on comparison with
data produced with labelled target produced using conven-
tional methods, we employed two complementary analyses of
the 28 relevant datasets. First, we utilised a statistical
analysis of variance (ANOVA) to ascertain the major deter-
minants of differences across all data sets. Secondly, we
identi®ed differentially expressed genes observed in all data
sets and determined the similarity between these sets of
outliers across the three different target production and
labelling techniques.
Analysis of variance (ANOVA). The Levene's homogeneity of
variance test (19) is utilised to examine the distribution of the
individual data sets and test for equality of variances within
the set, an assumption necessary for ANOVA. Application of
this test to a random subset of genes from our data set was
found to be not signi®cant (throughout the ANOVA analysis
signi®cance was tested at the 95% level). To test for
differences between methodologies we performed ANOVA
(using SPSS) on the log-transformed ratios for each hybrid-
isation. We examined the variation arising from methodology,
replicates, amount of starting material, colour swaps and
cDNA synthesis.
Variation between the datasets grouped by the three
methodologies was found to be signi®cant [Table 2(a)]. To
ascertain the cause of this difference further analysis was
undertaken. On examination of the variation within each
methodology [Table 2(b)] there was a highly signi®cant
difference between the RT replicates, although no signi®cant
difference was observed between Klenow replicates and
between SPA replicates, respectively. Comparing all data
sets, variation between the two colour swap orientations
is highly signi®cant [Table 2(c)], however, when this is
examined by methodology, the difference is only found in the
RT group [Table 2(d)]. Perhaps surprisingly, the variation
within ampli®cation due to the amount of starting material
used was not signi®cant [Table 2(e)]. This was still not
signi®cant when comparing across all methodologies.
Variation between cDNA syntheses [Table 2(f)] was highly
signi®cant and this accounted for the majority of variation
Figure 1. (A) A schematic overview of the three methods compared. In the
RT experiments ®rst-strand cDNA is ¯uorescently labelled through incorp-
oration of Cy3-dCTP or Cy5-dCTP by reverse transcriptase. Samples are
combined and hybridised to the microarray. (B) For the Klenow experi-
ments cDNA is ¯uorescently labelled through random primed Klenow
extension following ®rst-strand cDNA synthesis. (C) In the SPA experi-
ments double-stranded cDNA is entered for ampli®cation and the resultant
products labelled by random primed Klenow extension. (D±F) False colour
overlay images of the same subsection of the array hybridised with cDNA
derived from (D) 100 mg total RNA labelled with RT cDNA, (E) 20 mg of
total RNA labelled with Klenow and (F) SPA cDNA equivalent to 0.031 mg
total RNA.
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observed across all data sets. A Bonferroni test indicated that
several of the cDNA syntheses used are different but these are
not con®ned to any one method consistently.
Identi®cation of outliers. Lists of outliers [cDNA spots with
differential expression above the set threshold (see Materials
and Methods)] were generated to ascertain the ability of each
methodology to reproducibly identify outliers. The lists
generated from each of the methodologies were in turn set
as the benchmark and the ability of other methodologies to
reproducibly identify this list was then determined (Fig. 2).
These data demonstrate that the SPA procedure allows
identi®cation of outliers as consistently as RT-based and
Klenow-based labelling methods. A PubMed survey of
known genes consistently identi®ed as outliers con®rmed
relative expression differences highlighted by the microarray
hybridisations (Fig. 2 and additional material).
DISCUSSION
SPA is a reproducible and reliable method of target ampli®-
cation for differential gene expression screens using cDNA
microarrays. Not only does it identify outlier genes as
ef®ciently as conventional methods, but also does so employ-
ing as little starting material as 32 ng total RNA.
The small level of disparity observed between SPA and the
other techniques examined during this study can, for the most
part, be attributed to the initial cDNA synthesis step, at present
an unavoidable step for all microarray analysis. The ampli-
®cation itself does not signi®cantly increase the overall
variability above that encountered during cDNA synthesis.
Indeed, self±self hybridisation of independent ampli®cations
demonstrates this point quite clearly.
Surprisingly, the amount of starting material was not found
to be signi®cant within the SPA hybridisations. A priori, we
would have expected reproducibility to diminish as starting
material was reduced. The observation that it does not
suggests that 30 ng does not represent the lower limit of this
technique. Indeed, recent experiments utilising this technique
suggest that outlier identi®cation may be possible using total
RNA extracted from as few as 10 cells (Birgit Liss, University
of Oxford, Oxford, UK, personal communication).
Our data also demonstrate that the ability to reproducibly
identify outliers is undiminished in comparison to the other
methods employed. The limitation for inclusion in the central
grouping of Figure 2 (genes signi®cant in all methods) is that
the differential expression must have been observed in all 28
hybridisations. Omission from the central grouping is for the
most part the result of failure of a single hybridisation to
identify a differential greater than the threshold set. By visual
inspection of the raster plots in Figure 2 it is clear to see that
outliers identi®ed by one technique are for the most part
similarly coloured in the other two techniques, albeit below
the 28 experiment detection threshold.
Although the ef®cacy of the SPA technique is apparent, the
precise mechanism of ampli®cation is unclear. The ef®ciency
with which target can be produced from a small amount of
starting material indicates that a model based on a merely
linear reaction involving synthesis of one antisense cDNA
copy per molecule at each round of extension is untenable.
Rather, it is more likely that a combination of priming from
the incorporated heel primer at the 3¢ end of each cDNA
molecule and mismatch priming at multiple sites transcrip-
tome-wide results in levels of ampli®cation signi®cantly
greater than linear, though falling short of the exponential
levels associated with standard PCRs. Allied to this, Klenow
labelling itself appears to possess a strand-switching function.
First-strand cDNA labelled with Klenow recapitulates outlier
identi®cation when hybridised to slides arrayed with amino-
linked sense strand cDNAs (data not shown). This was also
observed when using sense oligonucleotide arrays. This
suggests that further `ampli®cation' occurs during the
labelling step that not only increases signal, but also allows
hybridisation to both sense and antisense strands.
Table 2. Summary of ANOVA results for each source of variation
Source d.f. F Signi®cance
(a) Variation between RT, Klenow and SPA 2 4.53 0.01076a
(b) Variation within RT 3 6.54 0.00021b
Variation within Klenow 3 1.04 0.37375
Variation within SPA 19 0.79 0.71678
(c) Variation between colourswap 1 15.61 0.00008b
(d) Variation between colourswap within RT 1 19.50 0.00001b
Variation between colourswap within Klenow 1 2.48 0.11538
Variation between colourswap within SPA 1 3.29 0.06988
(e) Variation between amount of starting material (only within SPA) 4 0.32 0.86389
Variation between amount of starting material (across all experiments) 6 1.70 0.11635
(f) Variation between cDNA syntheses 7 5.16 0.00001b,c
(a) The variation between the three methodologies (RT incorporation, Klenow and SPA with Klenow labelling) is shown to be highly signi®cant. (b) When
examined within each of the three methodologies the variation is only signi®cant within RT. (c) Differences between the two dye orientations are found to be
highly signi®cant across all data but when separated into methodologies (d) the differences are only signi®cant within RT. (e) The amount of starting material
used does not cause signi®cant differences either within the SPA ampli®cation or across all methodologies. (f) Examination of how the cDNA synthesis
affects variation across all data shows highly signi®cant results; to identify the cause of these differences a Bonferroni test was used to compare the individual
cDNA synthesis to each other and identify which samples are different.
Signi®cance is tested using the F distribution at the 95% con®dence level.
aSigni®cant differences.
bHighly signi®cant.
cA Bonferroni post hoc test was performed to identify the cause of the signi®cant differences between cDNA synthesis and showed that there were
differences between the following pairs of cDNA synthesis reactions: cDNA 1 versus 3; 1 versus 7; 1 versus 8; 3 versus 5; 5 versus 7; 5 versus 8; 6 versus 7,
6 versus 8.
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The data presented here also indicate the ef®cacy of
incorporation of Cy dyes using Klenow fragment and random
priming of ®rst-strand cDNA. The signal intensity routinely
obtained with 20 mg of total RNA is at least equivalent to that
observed with conventional direct incorporation by reverse
transcriptase of 100 mg of total RNA. The analyses performed
also con®rm that cDNA synthesis and labelling represent
signi®cant causes of variation between identical RNA samples
and reaf®rm the need for replicate hybridisations and, in the
case of RT labelling, dye-swap replicates.
The experiments described here were performed on aliquots
of total RNA that had previously been examined for high
quality, e.g. absence of signi®cant degradation. In real world
examples of the use of limiting tissue samples such quality
control measures may be impossible. We have recently used
the SPA technique on total RNA extracted from individual
male and female embryonic mouse gonads, equivalent to
~200 ng, and have reliably detected appropriate expression of
tissue-speci®c control genes and highlighted several novel
genes not previously ascribed a sexually dimorphic expression
pattern in the developing gonad (L.Sith and A.Green®eld,
manuscript in preparation).
In conclusion, the Taq-based SPA protocol described here
has certain advantages over previously published techniques.
The simplicity of the protocol, requiring no modi®cation,
ligation or RNA ampli®cation steps, will appeal to researchers
wishing to rapidly characterise differential gene expression
using DNA microarrays in cases of limiting tissue availability.
This especially applies to those researchers with no previous
experience in microarray sample preparation, as many will be
familiar with the similar cycle sequencing protocol. Due to the
stable DNA-based nature of the technique this methodology
will also lend itself well to high throughput analysis of
multiple small tissue samples. Our primary aim was also to
develop a technique for microarray sample preparation that
addressed the sometimes prohibitive costs associated with
other methodologies. The technique itself uses off-the-shelf
reagents rather than requiring expensive kits and thus can be
considered an attractive alternative for researchers with
limited funds.
Additional material is available from www.mgu.har.mrc.
ac.uk/microarray/ampli®cation. This includes the original tif
image ®les generated from the 30 microarrays, the signal
intensity results for each channel of each microarray and a
detailed table of homologies associated with previously
published expression data.
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